市場調查報告書
商品編碼
1433400
全球婦科器材市場 2023-2030Global Gynecological Devices Market 2023-2030 |
預計在預測期(2023-2030年),全球婦科設備市場將以7.9%的CAGR成長。該市場的成長歸因於全球對改進診斷的需求不斷成長。具有改進診斷能力的設備需求量很大,因為它更注重早期檢測和預防性醫療保健。例如,2023年10月,Olympus Corporation推出了下一代EVIS X1內視鏡系統。 TXI技術提高了病灶和息肉的可見度,RDI檢測深層血管和出血色素沉著,BAI-MAC提高黑暗區域的亮度水準,NBI在EVIS X1內視鏡設備上觀察黏膜和血管模式。它還具有用於加快處理速度的觸控面板和用於個人化影像配置的 MyCV 模式。
全球婦科設備市場分為內視鏡設備、子宮內膜消融設備和避孕設備。根據內視鏡設備,市場細分為子宮腔鏡、電切鏡、陰道鏡、腹腔鏡和內視鏡成像系統。依子宮內膜消融設備,市場分為球囊消融設備、水熱消融設備、射頻消融設備等。此外,根據避孕裝置,市場細分為臨時節育、永久性節育、診斷影像系統、液體管理系統等。腹腔鏡企業子類別預計將佔據內視鏡設備領域的很大一部分市場。這種成長可歸因於腹腔鏡手術的眾多好處,包括失血量少、住院時間短以及術中和術後問題較少。
在內視鏡設備中,子宮腔鏡細分市場預計將在全球婦科設備市場中佔據相當大的佔有率。細分市場的成長歸因於對提高技能和護理品質的需求不斷成長。改良的培訓方法可以培養出更熟練的從業人員,最終提高子宮腔鏡患者的治療品質。例如,2021年2月,VirtaMed推出子宮腔鏡和婦科腹腔鏡混合實境平台。子宮腔鏡訓練涵蓋16 個MyoSure 組織切除實例,以及50 多個診斷、息肉切除術、子宮肌瘤切除術、組織消融和高級電外科切除術實例,所有這些都具有基於能力的客觀回饋和併發症管理。婦科腹腔鏡模擬器模擬手術狀況。
全球婦科設備市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本、韓國和亞洲其他地區),以及世界其他地區(中東和非洲以及拉丁美洲)。其中,預計亞太地區將在全球市場中佔據顯著佔有率,因為人們對節育和避孕的認知不斷增強,政府尋求減少人口成長,可以提振該地區的產品需求。根據世界衛生組織的資料,2023年9月,過去二十年來,婦女對計劃生育的需求顯著增加,從2000年的9 億增加到2021年的約11 億。此外,現代避孕技術的採用也促進了婦女的計劃生育需求。增加,從2000年的6.63 億增加到2020年的8.51 億。根據預測,到2030年,預計將有7000 萬女性超過這一結果,避孕普及率呈現良好趨勢,從47.7%增加到49.0%2000年至2020年間。
事實
Global Gynecological Devices Market Size, Share & Trends Analysis Report by Endoscopy Devices (Hysteroscope, Resectoscope, Colposcope, Laparoscope, and Endoscopic Imaging Systems), by Endometrial Ablation Devices (Balloon Ablation Devices, Hydrothermal Ablation Devices, Radiofrequency Ablation Devices, and Others) and by Contraceptive Devices (Temporary Birth Control, Permanent Birth Control, Diagnostic Imaging Systems, Fluid Management Systems, and Others), Forecast Period (2023-2030)
The global gynecological devices market is anticipated to grow at a CAGR of 7.9% during the forecast period (2023-2030). The market's growth is attributed to the growing demand for improved diagnostics across the globe. Devices that have improved diagnostic capabilities are in high demand, as it contains an increased focus on early detection and preventive healthcare. For Instance, in October 2023, Olympus Corporation, launched next-generation EVIS X1 endoscopy system. The TXI technology improves visibility of lesions and polyps, RDI detects deep blood vessels and bleeding pigmentation, BAI-MAC improves brightness levels in dark areas, and NBI observes mucosal and vascular patterns on the EVIS X1 endoscopy equipment. It additionally features a touch panel for faster processes and a MyCV mode for personalized image configurations.
The global gynecological devices market is segmented on the endoscopy devices, endometrial ablation devices, and contraceptive devices. Based on the endoscopy devices, the market is sub-segmented into hysteroscope, resectoscope, colposcope, laparoscope, and endoscopic imaging systems. Based on the endometrial ablation devices, the market is sub-segmented into balloon ablation devices, hydrothermal ablation devices, radiofrequency ablation devices, and others. Furthermore, on the basis of contraceptive devices, the market is sub-segmented into temporary birth control, permanent birth control, diagnostic imaging systems, fluid management systems, and others. The laparoscope enterprise subcategory is expected to capture a significant portion of the market share within the endoscopy devices segment. The growth can be attributed to the numerous benefits of laparoscopic surgeries, including less blood loss, shorter hospital stays, and fewer intraoperative and postoperative issues.
Among the endoscopy devices, the hysteroscope sub-segment is expected to hold a considerable share of the global gynecological devices market. The segmental growth is attributed to the growing demand for improvement of skills and care quality. The improved training methods result in more skilled practitioners, ultimately improving the quality of treatment produced to hysteroscopic patients. For instance, in February 2021, VirtaMed launched hysteroscopy and gynecological laparoscopy mixed reality platform. Hysteroscopy training covers 16 instances for MyoSure tissue removal in addition to over 50 cases in diagnostics, polypectomy, myomectomy, tissue ablation, and advanced electrosurgical resection, all with competency-based objective feedback and complication management. The Gynecological Laparoscopy Simulator simulates surgical situations.
The global gynecological devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the growing awareness of birth control and contraception can boost regional product demand as a result of government seeks to reduce population growth. According to the World Health Organization, in September 2023, the demand for family planning among women has increased significantly over the last two decades, rising from 900 million in 2000 to approximately 1.1 billion in 2021. In addition, the adoption of contemporary contraceptive techniques has increased, rising from 663 million in 2000 to 851 million in 2020. According to projections, an additional 70 million women are projected to exceed the results by 2030, establishing a favorable trend in contraceptive prevalence rates, that have increased from 47.7% to 49.0% between 2000 and 2020.
Facts
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the optical technologies in a variety of applications across the region. The deployment of proceeds across endoscopy, pulse oximetry, laparoscopy, ophthalmology, and robotic surgery within the optical sector indicates the numerous applications of optical technologies. Its subsector targets distinctive clinical demands, ranging from minimally invasive surgical procedures to accurate diagnostic instruments, to satisfy a wide range of healthcare needs. According to the National Institute of Health (gov.) in December 2023, in imagining technology development, it is essential to evaluate the expenditure in research and development. By analyzing funding from the US National Institutes of Health (NIH), it emerged that radiological sectors receive $8.5 billion per year, accounting for 70% of device-based research, while optical sectors receive $3.6 billion per year, accounting for 30% of research, divided into microscopy, endoscopy, pulse oximetry, laparoscopy, ophthalmology, and robotic surgery. However, several technologies, such as MRI, nuclear medicine, and microscopy, have significant financing rates, with over 30% investment per technology valuation.
The major companies serving the gynecological devices market includes Elekta GmbH, FUJIFILM Corp., GE HealthCare Technologies Inc., Hologic, Inc., Johnson & Johnson Services, Inc. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in in February 2023, Samsung Launched new AI-Enabled OB/GYN Ultrasound System. The use of the Advanced MV-FlowTM feature and a large organic light-emitting diode (OLED) display that allows improved characterization of varied ultrasound pictures, delivers 2D and 3D imaging of microcirculatory and sluggish blood.